SN
Shah Nikita
Président Exécutif
OtherF
Insider track record
CEONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Shah Nikita, Président Exécutif. Director active across 1 company, notably Amneal Pharmaceuticals, Inc.. Cumulatively, 21 filings have been logged. Breakdown: 0 buy · 7 sells. Total volume traded: €5.2m. Activity tracked since 15 December 2021. The latest transaction was filed on 12 August 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Shah Nikita
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
146,403 shares@ US$17.51Class A Common StockSEC:0001628280-26-056757:0
36,232 sharesClass A Common StockSEC:0001628280-26-015235:0
36,331 shares@ US$2.752.8% of flowClass A Common StockSEC:0001628280-25-052413:0
114,492 shares@ US$9.6631.9% of flowClass A Common StockSEC:0001738061-25-000004:0
71,694 shares@ US$9.2928.1% of flowClass A Common StockSEC:0001723128-25-000052:0
50,000 shares@ US$9.0426.5% of flowClass A Common StockSEC:0001723128-25-000050:0
49,140 shares@ US$7.5830.7% of flowClass A Common StockSEC:0001628280-25-026513:0
36,232 sharesClass A Common StockSEC:0001628280-25-010678:0
28,958 sharesClass A Common StockSEC:0001628280-25-010113:0
100,000 shares@ US$7.7565.0% of flowClass A Common StockSEC:0001628280-24-037557:0
28,957 sharesClass A Common StockSEC:0001628280-24-008945:0
35,620 sharesClass A Common StockSEC:0001628280-24-007994:0
36,232 sharesClass A Common StockSEC:0001209191-23-016934:0
18,064 shares@ US$1.923.0% of flowClass A Common StockSEC:0001209191-23-016934:1
11,729 sharesClass A Common StockSEC:0001209191-23-015519:0
35,620 sharesClass A Common StockSEC:0001209191-23-014120:0
4,442 sharesClass A Common StockSEC:0001209191-22-028163:0
11,728 sharesClass A Common StockSEC:0001209191-22-016055:0
35,620 sharesClass A Common StockSEC:0001209191-22-014142:0
2,000 shares@ US$3.950.2% of flowClass A Common StockSEC:0001209191-21-070257:0
4,441 sharesClass A Common StockSEC:0001209191-21-031566:0
About Shah Nikita
Shah Nikita is Président Exécutif and Executive Vice President at Amneal Pharmaceuticals, Inc. He has 20 filings in total, and across the 20 sampled filings from 2021-05-11 to 2026-03-05, the reported transactions are exclusively sales, for a total of EUR 2954599, with the dominant transaction nature stated as Levée d'options.